These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
518 related articles for article (PubMed ID: 19342958)
1. Novel secondary hormonal therapy in advanced prostate cancer: an update. Van Allen EM; Ryan CJ Curr Opin Urol; 2009 May; 19(3):315-21. PubMed ID: 19342958 [TBL] [Abstract][Full Text] [Related]
2. Novel concepts in androgen receptor blockade. Hsieh AC; Ryan CJ Cancer J; 2008; 14(1):11-4. PubMed ID: 18303477 [TBL] [Abstract][Full Text] [Related]
3. The case for secondary hormonal therapies in the chemotherapy age. Small EJ; Ryan CJ J Urol; 2006 Dec; 176(6 Pt 2):S66-71. PubMed ID: 17084172 [TBL] [Abstract][Full Text] [Related]
9. Mechanisms leading to the development of hormone-resistant prostate cancer. Kasper S; Cookson MS Urol Clin North Am; 2006 May; 33(2):201-10, vii. PubMed ID: 16631458 [TBL] [Abstract][Full Text] [Related]
10. Alternative nonsteroidal antiandrogen therapy for advanced prostate cancer that relapsed after initial maximum androgen blockade. Suzuki H; Okihara K; Miyake H; Fujisawa M; Miyoshi S; Matsumoto T; Fujii M; Takihana Y; Usui T; Matsuda T; Ozono S; Kumon H; Ichikawa T; Miki T; J Urol; 2008 Sep; 180(3):921-7. PubMed ID: 18635218 [TBL] [Abstract][Full Text] [Related]
11. Stepping-stones to the further advancement of androgen-deprivation therapy for prostate cancer. Nishiyama T; Suzuki K; Yamana K; Tonegawa E; Wako K; Takahashi K Expert Rev Anticancer Ther; 2006 Feb; 6(2):259-68. PubMed ID: 16445378 [TBL] [Abstract][Full Text] [Related]
12. Drug insight: role of the androgen receptor in the development and progression of prostate cancer. Taplin ME Nat Clin Pract Oncol; 2007 Apr; 4(4):236-44. PubMed ID: 17392714 [TBL] [Abstract][Full Text] [Related]